Market Size (2021)
$198.42B
Vertical: CNMBase Year: 202112 Sections
Market Size (2021)
$198.42B
Projected (2027)
$254.31B
CAGR (2018–2027)
4.1%
Key Players
11+
The global oilfield biocides market was valued at USD 3,82,078.2 thousand in 2017 and is expected to register a CAGR of 7.33% to reach to USD 5,85,143.0 thousand by the end of 2023.
The growth of the global oilfield biocides market is mainly driven by the significant growth of the oil and gas industry with the increase in the demand for energy in developing countries on account of rapid industrialization. Likewise, the growing preference for hydraulic fracturing technology, which requires large volumes of water, in the oil and gas exploration is expected to boost the demand for biocides and drive the growth of the global market during the forecast period. Additionally, the increase in oil and gas exploration activities in the developing nations is likely to create significant opportunities for the players operating in the global oilfield biocides market.
However, the shifting preference towards renewable energy sources such solar, wind, geothermal, biomass, and hydropower energy as an alternative to traditional fossil fuels and increasing environmental regulations pertaining to carbon emissions is expected to hamper the growth of the global oilfield biocides market during the review period.
The global oilfield biocides market has been segmented based on type, application, and region. By type, the global market has been segmented into glutaraldehyde, THPS [tetrakis (hydroxymethyl) phosphonium sulfate], TTPC [tributyl tetradecyl phosphonium chloride], DBNPA, QAC (quaternary ammonium compounds), bronopol, and others.
Based on application, the global market has been segmented into upstream, midstream, and downstream. The upstream segment has been further sub-segmented into drilling protection, crude oil treatment, hydraulic fracturing operations, produced water treatment. The midstream segment has been further sub-segmented into crude oil transportation and storage, and pipeline pigging and scraping operations. The downstream segment has been further sub-segmented into fuel treatment and others. Among these, the upstream segment accounted for the largest share of the global oilfield biocides on account of the presence of large number of microorganisms in offshore drilling.
The global market, by region, has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global oilfield biocides market in 2017 due to the growth of the oil and gas industry with an increase in oil drilling activities and government support. Oil and gas exploration activities are likely to increase in Europe in the coming years. The markets in Asia-Pacific and the Middle East and North Africa are expected to grow at a significant rate during the review period on account of increase in exploration and production activities and startup of new oil and gas production projects. Additionally, the Latin American market is expected to register a moderate CAGR owing to increased spending on exploration and production activities by private and foreign companies in Mexico.
The Oilfield Biocides Market market is projected to grow at a CAGR of 4.1% from 2018 to 2027.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansBiocides are used to prevent or treat various types of bacteria and algae in drilling fluids and pipes. As bacteria and associated enzymes can degrade the fluids, lead to corrosion or cause pitting in pipes and equipment, and may create hydrogen sulfide, a highly toxic and dangerous gas.
To provide detailed analysis of the market structure along with forecast for the next five years of various segments and sub-segments of the global oilfield biocides marketTo provide insights about factors affecting the market growthTo analyze the global oilfield biocides market based on various tools such as supply chain analysis, and Porter’s five force analysisTo provide historical and forecast revenue of the market segments and sub-segments with respect to regions and their respective key countriesTo provide country level analysis of the market with respect to the current market size and future prospectiveTo provide country level analysis of the market for segments by type, application, and regionTo provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the marketTo track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global oilfield biocides market
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Process
Wantstats research is conducted by industry experts who offer insight into industry structure, market segmentations, technology assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.
Primary Research
Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
Secondary Research
Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the oilfield biocides Market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases and many others.
Market Size Estimation
Both, top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent submarkets of the overall Oilfield biocides market. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research. This entire procedure included the study of the annual and financial reports of top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market have been covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data. This data has been consolidated and added with detailed inputs and analysis from Wantstats and has been presented in this report. The following figure shows an illustrative representation of the overall market size estimation process employed for the purpose of this study
Base Year
2021
Historical Period
2018 – 2020
Forecast Period
2022 – 2027
Primary Interviews
150+
Historical data (2018–2021) and forecast period (2021–2027)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe global oilfield biocides market is projected to register a healthy CAGR of 7.33% during the forecast period. The growth of the global market is attributed to the high demand in the oil & gas industry. The oil and gas exploration activities are increasing in North America and Latin America due to rise in the number of projects, such as an offshore project in Brazil named Libra Field, which costs up to USD 91 billion, and the Johan Castberg Project in Norway, which costs around 5.92 billion. The growing oil & gas exploration activities is increasing the need for oilfield biocides that prevent the growth of microorganisms in hydraulic fracturing operations, wastewater treatment, and drilling protection. Investments in the oil & gas industry are increasing the exploration and production of unconventional resources. The rising concern regarding depleting conventional resources is likely to increase the adoption of hydraulic fracturing technology in the oil and gas industry, which is a key factor expected to boost the growth of the global oilfield biocides market. The emerging demand for oilfield biocides from India and China on account of rapid industrialization is also expected to boost the global market growth.
The companies operating in the global oilfield biocides market are launching new products, making strategic initiatives such as expansion and collaborations with other industrial players to achieve competitive advantage and higher market value. Furthermore, due to environmental regulations and incentives provided by the government to use renewable energy the end-use industries are likely to shift towards renewable sources of energy. The increasing investment in the oil & gas exploration activities in the developing countries such as India, China, Thailand, Malaysia, Indonesia, and Iran is projected to create growth opportunities for the players in the global oilfield biocides market.
The key players operating in the global oilfield biocides market include DowDuPont Inc. (US), Solvay (Belgium), BASF SE (Germany), Lonza (Switzerland), Kemira Oyj (Finland), Schülke & Mayr GmbH (Germany), Evonik Industries AG (Germany), BWA WATER ADDITIVES (UK), Pilot Chemical Corp (US), Stepan Company (US) and Nouryon (Egypt). The global oilfield biocides market comprises large-scale companies that offer similar kinds of products, which results in a high degree of rivalry among the players. Furthermore, stringent government regulations imposed on oilfield biocides products owing to its harmful effects on the environment and human health has influenced the industrial players to focus on innovation and development of bio-based oilfield biocides.
Threat of New Entrants
The global oilfield biocides market is expected to witness a moderate threat of new entrants during the review period. Although the use of biocides is subject to environmental regulations such as BPR, Fifra, and the OSPAR Convention, the increasing oil & gas exploration and production activities in the developing countries is likely to result in the entry of new players in the global oilfield biocides market.
Intensity of Rivalry
The global oilfield biocides market comprises of tier 1, tier 2, and other unorganized players. At present, the intensity of rivalry among the players operating in the global oilfield biocides is moderate, but with the expansion of the oil and gas industry in the coming years, the market players are likely to introduce new products and expand their presence in the developing nations. This is likely to intensify the rivalry among the key market players.
Threat of Substitutes
The threat of substitutes in the global oilfield biocides market is expected to be low as no direct substitutes to biocides are available in the global market.
Bargaining Power of Suppliers
The bargaining power of suppliers is expected to be low to moderate, as the market is fragmented with various organized and unorganized players and the switching cost to the buyers is also low. However, the introduction of new products with different properties such as AQUCAR biocide launched by DowDuPont to be suitable in cold weather is likely to result in the moderate bargaining power of the suppliers.
Bargaining Power of Buyers
The bargaining power of buyers is expected to be moderate to high as there are numerous choices available for the buyers wherein, they can switch easily. However, some players provide products of high quality and enhanced features, which becomes a differential factor in their offering and thus, the buyer’s power, in this case, remains moderate.
Market estimates by geography (2027)
InsightNorth America leads with $115.86B by 2027, while Middle East and Africa is projected to grow fastest at a 4.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2018 | 2021 | 2027 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $81.81B | $97.31B | $115.86B | 3.9% | 46% |
| Europe | $30.61B | $34.65B | $39.57B | 2.9% | 16% |
| Asia Pacific | $41.88B | $51.90B | $63.81B | 4.8% | 25% |
| South America | $8.48B | $10.19B | $12.24B | 4.2% | 5% |
| Middle East and Africa | $14.85B | $18.50B | $22.83B | 4.9% | 9% |
| Total | $177.64B | $212.55B | $254.31B | 4.1% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$254.31B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Upstream | $136.93B | 4.1% | 54% |
| Downstream | $74.80B | 4.7% | 29% |
| Midstream | $42.58B | 3.1% | 17% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Oilfield Biocides Market covering market dynamics, competitive landscape, and strategic outlook.
The Oilfield Biocides Market market is projected to reach $254.31B by 2027, growing at 4.1% CAGR. The Upstream segment holds the largest share.
The growth of the global oilfield biocides market is mainly driven by the growth of the oil and gas industry due to increasing energy demand mainly in India and China on account of rapid industrialization. The increasing investment in exploration and production of unconventional resources due to rising concern regarding depleting conventional resources is likely to increase the adoption of hydraulic fracturing technology in the oil and gas industry. The surge in the use of hydraulic fracturing has resulted in increased demand for water, which is derived from rivers, lakes, ponds, and recovered from previous fracturing treatments, which is expected to fuel the demand for oilfield biocides.
The increasing oil & gas production and extraction activities in the developing countries of Asia-Pacific and the Middle East & Africa is likely to create lucrative opportunities for the players operating in the global oilfield biocides market.
However, increasing preference for renewable energy sources to reduce greenhouse gas emissions is expected to hamper the global market growth in the coming years.
The use of biocide products such glutaraldehyde, THPS [Tetrakis (hydroxymethyl) phosphonium sulfate]n and DBNPA, in the offshore oil and gas industry is subject to approval by the EU’s Biocidal Product Regulations (BPR); EPA’s Federal Insecticides, Fungicide, and Rodenticide Act (Fifra); and the OSPAR Convention, a convention for the Protection of the Marine Environment of the North-East Atlantic, due to the harmful effects of some of the biocides on humans and the environment. The EU BPR came into effect on 1 September 2013. The BPR evaluates the safety of active substances used in biocidal products and authorizes the use of biocidal products. Additionally, as of September 2015, biocidal products cannot be introduced in the EU market unless the substance or product supplier is not included in the Article 95 list in which the cost incurred to generate data required for evaluation of active substance is shared. In the US, the evaluation and approval of active substances are regulated under the Fifra.
The use of chemicals in the offshore oil and gas industry in the North Sea is also regulated under the OSPAR Convention. The regulations are set out in the OSPAR Recommendation 2000/2 for a Harmonized Mandatory Control System (HMCS), which is aimed at reducing the impact of offshore chemicals on the marine environment. Thus, the regulations on the use of biocides in the offshore oil and gas industry are expected to restrain the growth of the global market during the review period.
Biocides are used in all the stages of oilfield development, including initial drilling of wells, production of oil and gas, and in all the aspects of maintenance of the oilfield, including storage of oil and natural gas in geological conditions (in salt caverns or depleted reservoirs). The presence of microorganisms in the oilfield negatively impacts the drilling operations by degrading petroleum hydrocarbons and increasing the oil density, sulfur content, and viscosity, which results in disruption in oil extraction and processing technology. This has resulted in increased demand for oilfield biocides in the oil and gas industry. Thus, the growth of the oil and gas industry is expected to be the major factor driving the demand for biocides and the growth of the global market.
The crude oil prices declined in 2014 and affected the growth of the oil and gas industry due to various factors such as rapid production growth in the US; global demand slowdown, particularly in Europe and China; strengthening US dollar; and continuous production by OPEC to support global oil prices. But with the slight recovery in crude oil prices owing to a reduction in production of crude oil by OPEC and rising global demand, the oil and gas industry has witnessed significant growth in the recent years. The growth of the oil and gas industry is mainly driven by an increase in energy demand mainly in India and China on account of rapidly expanding industrialization. According to OPEC, oil and gas collectively are expected to continue to cater to more than half of the global energy needs by 2040. The growth of the end-use industries including automotive, aerospace, and petrochemicals is likely to support the growth of the oil and gas industry despite shifting focus towards renewable energy sources. The global production of unconventional oil increased from 1 million cubic meters to around 3 million cubic meters in 2017, and that of natural gas increased from 4.3 billion cubic meters in 2014 to nearly 11 billion cubic meters in 2017.
Additionally, the major players operating in the global oilfield biocides market are emphasizing on strengthening their oilfield business. In November 2015, BASF proposed to reorganize its oilfield and mining solutions business to develop innovative and sustainable products to cater to the global demand and optimize yield. Also, steps taken by the US government in 2018 to open all the US coastal waters for oil drilling is likely to drive the growth of the oil & gas industry and consequently the demand for oilfield biocides in North America.
Increasing investment in exploration and production of unconventional resources due to rising concern regarding depleting conventional resources is likely to increase the use of hydraulic fracturing technology in the oil and gas industry. The use of technology has grown on account of its superior benefits such as increased production and less carbon emissions. The hydraulic fracturing technology requires large volumes of water, which often originates from rivers, lakes, ponds, as well as recovered from previous fracturing treatments. However, the water derived from these sources is often infested with various microorganisms and aerobic & anaerobic bacteria, which may result in degradation of fracturing chemicals, downhole corrosion, and downhole flow impairment. This has increased the demand for biocides in various hydraulic processes which include preparation of fracturing water topside, decontamination of well, and long-term protection of the reservoir. Some of the commonly used biocides in hydraulic fracturing process include chlorine dioxide, tributyl tetradecyl phosphonium chloride, glutaraldehyde, bronopol, dimethyl oxazolidine (DMO), tris (hydroxymethyl)nitromethane (THNM), and peracetic acid (a mixture of high-purity hydrogen peroxide and acetic acid).
Hydraulic fracturing technique is also widely used in shale extraction due to its aforementioned benefits. According to the US Energy Information Administration (EIA), in December 2014, the US shale oil production stood at 5.23 Million barrels per day and is expected to reach to nearly 9–10 Million barrels per day by 2020. The growing shale oil production coupled with increased spending on shale oil and gas production by the major players operating in the US such as BP plc., Exxon Mobil Corporation, and Chevron Corporation is likely to increase the adoption of hydraulic fracturing technology, which is expected to boost the demand for oilfield biocides and fuel the growth of the global market during the forecast period.
The increasing oil & gas production and extraction activities in the developing countries of Asia-Pacific and the Middle East & Africa such as India, China, Thailand, Malaysia, Indonesia, Kuwait, Saudi Arabia, and Iran on account of the rising demand for petroleum products, fuel, and energy in numerous applications is likely to drive the growth of the oil and gas industry and thus, the demand for oilfield biocides. For instance, in 2017, the Indonesian Husky-CNOOC Madura Limited, a subsidiary of CNOOC Limited, started operations in the BD field for gas production. The company aims at producing 100 million standard cubic feet of gas per day (MMSCFD) and 7,000 barrels of condensate per day from the BD field.
CNOOC Limited started production at the Weizhou 12-2 oil field Phase II project in the Beibu Gulf in the South China Sea, which produces 6,400 oil barrels per day and is likely to expand production capacity to 11,800 barrels per day by the end of 2019. Moreover, the international players operating in the oilfield services industry, e.g., Baker Hughes, are also emphasizing on starting new projects in Asia-Pacific.
In the Middle East, the oil, gas and petrochemical projects worth USD 211 billion are under execution and projects worth USD 242 billion are in the various stages of pre-execution in countries including Saudi Arabia, Kuwait, Iran, UAE, Iraq, Algeria, Egypt, and Oman. Among the total projects under execution in the region, Saudi Arabia has around 80 active oil & gas contracts under execution, including nine projects worth USD 1 billion and the two largest projects, which are USD 16 billion Jizan refinery project and USD 6.5 billion Fadhili gas plant. Some of the other major projects under execution are USD 24 billion Clean Fuels Project, under Kuwait Integrated Petrochemical Industries Company and USD 20 billion New Refinery Project, under Kuwait National Petroleum Company.
The expanding automotive and transportation industry on account of the rising per capita disposable income and increasing international trade has increased the demand for fuel, which is likely to result in increased investment in oil exploration activities and thus, drive the demand for oilfield biocides.
Technological advancements and rising investments in infrastructure are also expected to increase the oilfield drilling activities and thus, create significant opportunities for the players operating in the global oilfield biocides market.
The growing use of renewable energy sources such solar, wind, geothermal, biomass, and hydropower energy as an alternative to traditional fossil fuels such as oil and coal is expected to hamper the growth of the global oilfield biocides market. The increasing environmental regulations to reduce carbon emissions is driving the demand for renewable energy sources primarily in the developed markets. In 2017, in the US, around 17% of the total electricity was generated from renewable energy. The consumption of biofuels and other nonhydroelectric renewable energy sources doubled from 2000 to 2017 owing to environmental regulations and incentives provided by the government to use renewable energy. Additionally, emission reduction targets set by the EU has increased the demand for renewable energy sources in Europe. For instance, the EU intends to reduce greenhouse gas emissions by 40% and increase the percentage of renewable energy sources to 27 in its total energy mix.
Furthermore, increased investment in solar and hydropower plants in the developing nations is also likely to hamper the global market growth. For instance, the Asian Infrastructure Investment Bank (AIIB) has established various renewable energy projects such as a solar power plant in Egypt and a coal replacement project in China as part of its lean, clean, and green motto under the Paris Agreement. Besides, the use of hydropower sources is increasing to meet the rising demand for green energy sources in both developing and developed countries.
The use of biocide products such glutaraldehyde, THPS [Tetrakis (hydroxymethyl) phosphonium sulfate]n and DBNPA, in the offshore oil and gas industry is subject to approval by the EU’s Biocidal Product Regulations (BPR); EPA’s Federal Insecticides, Fungicide, and Rodenticide Act (Fifra); and the OSPAR Convention, a convention for the Protection of the Marine Environment of the North-East Atlantic, due to the harmful effects of some of the biocides on humans and the environment. The EU BPR came into effect on 1 September 2013. The BPR evaluates the safety of active substances used in biocidal products and authorizes the use of biocidal products. Additionally, as of September 2015, biocidal products cannot be introduced in the EU market unless the substance or product supplier is not included in the Article 95 list in which the cost incurred to generate data required for evaluation of active substance is shared. In the US, the evaluation and approval of active substances are regulated under the Fifra.
The use of chemicals in the offshore oil and gas industry in the North Sea is also regulated under the OSPAR Convention. The regulations are set out in the OSPAR Recommendation 2000/2 for a Harmonized Mandatory Control System (HMCS), which is aimed at reducing the impact of offshore chemicals on the marine environment. Thus, the regulations on the use of biocides in the offshore oil and gas industry are expected to restrain the growth of the global market during the review period.
The use of biocide products such glutaraldehyde, THPS [Tetrakis (hydroxymethyl) phosphonium sulfate]n and DBNPA, in the offshore oil and gas industry is subject to approval by the EU’s Biocidal Product Regulations (BPR); EPA’s Federal Insecticides, Fungicide, and Rodenticide Act (Fifra); and the OSPAR Convention, a convention for the Protection of the Marine Environment of the North-East Atlantic, due to the harmful effects of some of the biocides on humans and the environment. The EU BPR came into effect on 1 September 2013. The BPR evaluates the safety of active substances used in biocidal products and authorizes the use of biocidal products. Additionally, as of September 2015, biocidal products cannot be introduced in the EU market unless the substance or product supplier is not included in the Article 95 list in which the cost incurred to generate data required for evaluation of active substance is shared. In the US, the evaluation and approval of active substances are regulated under the Fifra.
The use of chemicals in the offshore oil and gas industry in the North Sea is also regulated under the OSPAR Convention. The regulations are set out in the OSPAR Recommendation 2000/2 for a Harmonized Mandatory Control System (HMCS), which is aimed at reducing the impact of offshore chemicals on the marine environment. Thus, the regulations on the use of biocides in the offshore oil and gas industry are expected to restrain the growth of the global market during the review period.
Overview Of Supply Scenario
Production/ Supply Scenario
The outbreak of COVID-19 has had a negative impact on the production of oilfield biocides due to the disruption in the supply chain across the globe. In response, to protect workers from the spread of the new coronavirus, the companies in the market have restricted travel and face-to-face meetings for the employees. According to the United Nations, the global economy is projected to contract by around 3% or more instead of registering 2.5% growth projected by the World Economic Situation and Prospects report 2020.
The companies are working aggressively towards safeguarding the health and wellbeing of their employees while also supporting government goals of maintaining critical business activities, such as healthcare, power generation, and food production. Additionally, the transition by major players in this market to support the need for medical products is a key factor impacting the growth of the market. For instance, BASF SE started providing support to worldwide academic research groups to search for a suitable active ingredient to treat patients infected with the coronavirus. In March 2020, the company initiated the production of hand sanitizers at its Ludwigshafen site due to the COVID-19 outbreak reducing regular supplies. The company has reallocated several metric tons of raw materials, especially isopropanol, for making the sanitizers.
The supply scenario is facing a few issues due to the restrictions on travel and the lockdown of cities; however, the sourcing teams are working closely with the suppliers to manage the supply of raw materials proactively. Companies are closely monitoring and managing the extent and duration of any local requirements impacting their physical locations. WCS, the Canadian heavy oil price, which traditionally lags behind WTI, was hovering near USD 22, with the lowest differential between the two in over a decade. The volatility in the oil price for the next several months is expected to be continued due to shortages and over-supply until demand begins to recover.
Impact On Oilfield Biocides Suppliers
The majority of raw materials suppliers in this market had to shut down their operating facilities due to the outbreak of COVID-19. In response to combat the virus, the key suppliers shifted their focus toward offering relief in the pandemic. However, these companies have begun operations again. They are following necessary measures, such as the enforcement of wearing masks, washing hands, sanitizing, social distancing, temperature monitoring, frequent clean down, and disinfection within facilities.
The major companies operating in the chemical industry getting affected due to coronavirus outbreak include BASF SE, DowDuPont, China Petroleum & Chemical Corp., SABIC, Mitsubishi Chemical Corp., Wanhua Chemical Corp., Chevron Phillips Chemical, Evonik Industries, Jianshi Yuantong Bioengineering Co., Ltd., PPG Industries, and The Linde Group. Looking at the situation, many chemical companies have halted their production facilities across the globe. Some other companies, which are still working, are operating at only 40-60% efficiency.
Impact On Oilfield Biocides Manufacturers
Manufacturers in this market have decreased their production capacities owing to the decline in demand from the end-use industries, reduced prices, and disruptions in the supply of raw materials. The outbreak has severely impacted the demand from end-use industries, which has resulted in a decline in the production of oilfield biocides. Moreover, players are focused on COVID-19 relief and are acting for the same.
The manufacturers are taking a toll due to reduced demand for products and have announced reduced capital for their prospects. Through its affiliate Imperial Oil Limited, the company offered 80,000 Esso and Mobil fuel vouchers worth USD 2 million to frontline nurses, paramedics, and doctors as part of its Heroes Campaign in Canada.
Impact On Oilfield Biocides End Users
The restrictions on travel and transportation coupled with strict lockdown resulted in low availability of manpower for upstream, downstream, and midstream oil & gas activities. This is due to the reduced outings, closed working places, and lockdown. On the other hand, the energy & power sector witnessed a spike in demand and has witnessed higher than usual consumption, which is expected to re-normalize in the coming years.
Profiles of 109 companies operating in the Oilfield Biocides Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Company Headquarters: Illinois, US Founded: 1932 Workforce: ~2,250 Company Working: Stepan Company (Stepan) is engaged in the manufacturing and sale of specialty and intermediate chemicals. It operates through the segments, namely surfactants, polymers, and specialty products. Surfactants segment offers oilfield biocides along with a wide range of surfactant chemicals such as anionic, cationic, nonionic, and amphoteric surfactants. The polymers segment produces polyester polyols and phthalic anhydride. The specialty products are chemicals used in food, flavoring, nutritional supplement, and pharmaceutical applications.
Kemira is a Helsinki-headquartered, mid-cap specialty and commodity-adjacent chemicals producer that describes itself as a global leader in sustainable chemistry for water-intensive industries. With FY2025 revenue of EUR 2,753.5M and operative EBITDA of EUR 524.6M (19.1% margin), it is among the world's largest suppliers of water-treatment coagulants and polyacrylamide polymers. It is also a leading supplier of pulp bleaching chemicals (sodium chlorate, hydrogen peroxide) and of process and functional chemicals for packaging board, tissue and paper. After divesting Oil & Gas in February 2024, Kemira reorganised into three business units on 1 January 2025: Water Solutions (≈44% of revenue), Packaging & Hygiene Solutions (≈35%) and Fiber Essentials (≈20%). Its strategic ambition is to double water-related revenue, including a 2025 entry into US industrial water-treatment services. It also pursues EUR 500M+ of renewable-solutions revenue by 2030. The company is financially conservative (net debt/operative EBITDA 1.0x at end-2025) and is anchored by Oras Invest. In 2026 it is navigating a sharp, Iran-war-driven raw material and logistics cost shock. --- ### Company self-description (latest annual reporting, FY2025) Kemira presents itself as a global leader in sustainable chemistry for water-intensive industries. It serves municipal and industrial water-treatment customers and the fiber industry. Its solutions are positioned around securing clean water and supporting customers' circularity and resource-efficiency goals across their value chains. Its strategic pillars (as communicated since the 2024 strategy update) are profitable growth, with water as the principal growth engine, and renewable (bio-based) solutions as a long-term differentiation axis. ### Independent characterisation Kemira is best understood as a process-chemicals manufacturer with a "local-for-local" asset base. It operates 58 manufacturing facilities globally (FY2025 Board of Directors' Review). Its products are high-volume, relatively low-value-per-tonne chemicals (iron- and aluminium-based coagulants, sodium chlorate, hydrogen peroxide, caustic soda) where freight costs make proximity to customers a structural moat. These sit alongside higher-value functional chemistries (polyacrylamide flocculants, sizing agents such as AKD wax, dry- and wet-strength resins, defoamers, biocides, barrier chemistries). Value is added through application know-how, on-site service and, increasingly, digital dosing optimisation. The company's revenue model is overwhelmingly product sales under supply contracts. Water Solutions' municipal business is dominated by tendered, often fixed-price contracts, which explains the lag in passing through cost inflation highlighted in Q2 2026. Fiber Essentials sells bleaching chemicals under long-term agreements to pulp mills, in some cases from chemical "islands" co-located with customer mills. A nascent services revenue stream has been created through the acquisitions of Water Engineering, Inc. (October 2025), AquaBlue, Inc. (January 2026) and the Clear Water Technologies, LLC business (June 2026). These provide recurring industrial water-treatment programmes (boilers, cooling towers, wastewater) to food & beverage, healthcare, manufacturing, data-centre and commercial/institutional customers. Licensing revenue is immaterial and not separately disclosed. ### Revenue model mix (indicative) ### Value chain position Kemira sits in the mid-stream of the chemical value chain. It purchases basic inputs and converts them into formulated or commodity-grade process chemicals. Inputs include iron and aluminium sources (including industrial by-products such as iron sulphate from steel and TiO2 production), acrylonitrile/acrylamide-based monomers (oil-derived), electricity (critical for sodium chlorate electrolysis), salt, and fatty acids for AKD. Approximately one-third of raw materials are oil-based and mainly used for polymer production (June 2026 investor newsletter). Kemira is backward-integrated in electricity in Finland through shareholdings in Pohjolan Voima and Teollisuuden Voima (Mankala principle: power at production cost). This is a key cost advantage for energy-intensive sodium chlorate production. ### Customer types and end-markets
Lonza is the world's largest and longest-established pure-play contract development and manufacturing organization (CDMO). It sells development, manufacturing and technology services to pharmaceutical and biotechnology companies across the main modalities: - mammalian and microbial biologics; - small-molecule APIs and drug products; - antibody-drug conjugates (ADCs) and bioconjugates; - cell and gene therapies; - mRNA. Following the March 2026 agreement to sell Capsules & Health Ingredients (CHI) to Lone Star Funds, Lonza is completing a two-year transformation into a focused CDMO. It now operates three business platforms: Integrated Biologics, Advanced Synthesis and Specialized Modalities. Its differentiation rests on four things: - scale, including Visp, Vacaville (the largest US biologics CDMO site) and Portsmouth; - an integrated drug-substance-to-drug-product offering; - a proprietary toolbox: GS Xceed® expression, Ibex®, Synaffix® ADC linkers and the Nona TfR1 BBB technology; - a quality track record across 125+ years of chemical and biological manufacturing. FY2025 continuing sales were CHF 6.5bn at a 31.6% CORE EBITDA margin. Management guides FY2026 to 11–12% CER growth and a 33–34% margin. --- **Company's own description.** In its 2026 releases Lonza calls itself the world's leading CDMO "dedicated to serving the healthcare industry." It describes a team of around 20,000 people working with pharma and biotech customers to turn breakthrough innovations into viable therapies, using science, smart technology and lean manufacturing (H1 2026 release boilerplate). The FY2025 FYR and AR2025 present the business as three complementary, integrated CDMO Business Platforms "powered by the Lonza Engine®." The Lonza Engine is the company's term for its combined strengths in science, smart technology and lean manufacturing for complex and emerging modalities (6 Mar 2026 release). **What Lonza does.** Lonza takes a customer's molecule, from DNA sequence or chemical route, and develops and manufactures it. Work runs from pre-clinical development through clinical supply to commercial launch and lifecycle manufacturing. Revenue comes from four sources: - **Development services.** Cell-line development, process and analytical development, formulation and regulatory CMC. Typically billed fee-for-service or per milestone. - **Clinical and commercial manufacturing.** Drug substance and drug product. Usually batch-based or capacity-reservation contracts, often with take-or-pay or minimum-volume features. Large commercial deals are frequently multi-year and sometimes involve customer co-funding of dedicated capacity, as in the Ibex model and the 2026 Stein ADC line backed by a long-term customer commitment. - **Technology licensing.** GS Xceed® expression system licences, Synaffix ADC technology licences with upfront/milestone/royalty structures, bYlok® and the Nona TfR1 BBB platform. - **Products (Bioscience).** Cell-culture media, primary cells, transfection systems (Nucleofector™), endotoxin and microbial testing. Sold as consumables and instruments. **Revenue-model mix.** Lonza does not publish an exact split between product, service, subscription and licensing revenue. The analyst estimate is that more than 90% of continuing revenue is service-based CDMO revenue (development plus manufacturing). The rest is Bioscience products, reported within Specialized Modalities, and technology licensing. There is no subscription revenue. Licensing is strategically important as a customer-acquisition funnel but financially small; its amount is not separately disclosed. **Value-chain position.** Lonza sits between drug innovators (big pharma, mid-cap and small biotech) and patients. It is an outsourced manufacturer that carries large fixed-asset intensity: - PP&E of CHF 8.3bn at FY2025 (S&P/StockAnalysis); - CapEx of CHF 1.3bn in FY2025, 19.6% of sales (FY2025 FYR). Its upstream suppliers are equipment, single-use consumable, raw-material and media vendors. Downstream, its customers own the regulatory licences and commercialize the drugs. **Customer types:** 1. Large pharmaceutical companies outsourcing commercial capacity. Examples are the strategic multi-site US biopharma collaboration expanded on 1 Jul 2026 and the Vacaville commercial contracts. 2. Mid-size and emerging biotech needing integrated DNA-to-IND and clinical supply. Example: the ImmuneOncia late-stage mAb deal, March 2026. 3. Academic and research customers (Bioscience). 4. Cell and gene therapy developers (autologous and allogeneic). **End-markets.** The main end-markets are: - biologic therapeutics (mAbs, bispecifics, fusion proteins); - ADCs and bioconjugates in oncology; - small-molecule APIs including highly potent APIs (HPAPI); - cell and gene therapy; - microbial-derived proteins, peptides and enzymes; - mRNA/LNP; - research tools. **Analyst characterization.** Lonza is a capital-heavy, scale-advantaged infrastructure provider to biopharma. Its economics depend on asset utilization: - New plants dilute margins during ramp-up. This was visible in FY2023, when the CORE EBITDA margin fell to 29.8%, and in early Vacaville. - Mature, full assets earn returns well above group average. Advanced Synthesis reached a 48.1% CORE EBITDA margin in H1 2026. The CHI exit removes a lower-growth consumer-health and capsule business that lacked CDMO synergy. It turns Lonza into a purer "picks-and-shovels" exposure to biologic and complex-modality pipelines. The key debates are: - the pace of capacity absorption at Vacaville and Visp large-scale; - competitive intensity from Asian CDMOs and big-pharma insourcing; - capital intensity versus free-cash-flow conversion.
Evonik is Germany's second-largest listed chemicals group after BASF and one of Europe's broadest pure-play specialty chemicals companies, generating €14.1bn of sales and €1.87bn adjusted EBITDA in FY2025. Since April 2025 it has been organised into two operating segments — Custom Solutions (formulated, application-driven specialties for coatings, personal care, pharma, and industrial additives) and Advanced Technologies (scale- and technology-driven platforms in silica, hydrogen peroxide, high-performance polymers, crosslinkers and animal-nutrition amino acids) — plus an Infrastructure segment (SYNEQT site services, Oxeno C4 chemicals) earmarked for divestment. Its competitive identity rests on deep process know-how, integrated German Verbund sites (Marl, Wesseling, Rheinfelden, Essen, Hanau), and leadership positions in global niches (fumed silica, DL-methionine, PA12, pharma excipients/lipids). The investment case is a transformation story — €400m-plus cost reduction, portfolio pruning, deleveraging — now overlaid by a live takeover approach from BASF and a near-majority foundation shareholder whose stance is pivotal. --- ### Company self-description Evonik describes itself as a global chemical company that goes "beyond chemistry" by combining innovative strength with leading technological expertise, providing customers with a competitive advantage through tailor-made products and solutions — positioning itself as a "superforce for industry" (company boilerplate, press releases 2026; Company Factbook 2026). Its stated strategic pillars (Capital Markets Day, 22 May 2025) are: a differentiated portfolio in two segments, sustainable innovation, a balanced regional footprint (ambition of roughly one-third of sales in each of Americas, EMEA and Asia-Pacific), and a performance culture. ### Independent characterisation Evonik is a mid-cap, diversified specialty and "semi-specialty" chemicals manufacturer. Roughly 80% of FY2025 sales (€11.5bn of €14.1bn) came from the two core segments; the remaining ~18–19% came from Infrastructure & Other, which bundles low-margin site services and the cyclical C4 (Oxeno) petrochemical chain. The business is overwhelmingly a product business (manufactured chemicals sold B2B under supply contracts, frame agreements and spot), with smaller service/contract components: (i) pharma CDMO and contract manufacturing (Health Care — lipids/LNPs, drug substances, oral drug delivery), (ii) site infrastructure and utility services sold by SYNEQT to ~two dozen third-party companies in the Marl and Wesseling chemical parks, and (iii) licensing/technology (e.g., HPPO hydrogen peroxide technology with partners; catalysts). Subscription revenue is negligible. Precise revenue-model split (product vs service vs licensing) is n/d. ### Value-chain position Evonik sits mid-stream: it buys petrochemical feedstocks (C4 raffinate, propylene, methanol, ammonia, natural gas/energy, silicon metal, sulphur) and converts them into intermediates and formulated specialties sold to formulators and OEMs. Upstream integration is partial (own C4 cracking downstream of refinery/cracker streams at Marl and Antwerp; own HCN and methionine chain in Antwerp, Mobile and Singapore). Downstream, it rarely sells to consumers; its products are ingredients typically <5% of the customer's cost but critical to performance ("small cost share, high value-in-use"), which supports pricing power in the specialty businesses. ### Customer types and end markets Customers include paint and coatings formulators, adhesives and sealants makers, tyre and rubber producers (silica/silanes), cosmetic and household-care brands, pharmaceutical and biotech companies (excipients, lipids, CDMO), animal-feed mills and integrators (methionine), plastics and automotive suppliers (PA12, PEEK), aerospace (ROHACELL foams), pulp & paper, electronics and semiconductors (high-purity silanes/chlorosilanes, H2O2), renewable energy and hydrogen (membranes, catalysts), and biodiesel producers (alkoxide catalysts). End-market exposure is broad: consumer/personal care, health care, food/feed, automotive and mobility, construction, coatings, industrial, energy/agriculture. A precise end-market % split for FY2025 is n/d in sources reviewed.
Company Headquarters: Brussels, Belgium Founded: 1863 Workforce: ~27,000 Company Working: Solvay is engaged in the manufacturing and distribution of oilfield biocides. It operates through the following business segments, namely advanced formulations, advanced materials, performance chemicals, and advance formulation. It offers oilfield biocides under the advance formulation segment. The segment is dedicated to products which require customized specialty formulations for surface chemistry and liquid behavior, maximizing yield and efficiency, and minimizing eco-impact. Furthermore, the advance materials segment offers a solution for lightweight, energy-efficient and sustainable mobility and the performance chemicals segment offers chemical intermediaries. Moreover, the company operates in 62 countries and has 21 research and development centers across the globe.
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
8 interactive charts drawn from the Oilfield Biocides Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Oilfield Biocides By Application
Oilfield Biocides By TYPE
Oilfield Biocides Saudi Arabia, UAE, Israel, South Africa, Egypt and Rest Of Middle East And Africa
Oilfield Biocides Brazil, Mexico and Rest Of South America By Country
Oilfield Biocides China, Japan, India, Australia And New Zealand, Indonesia, South Korea, Malaysia, Thailand and Rest Of Asia Pacific
Oilfield Biocides Germany, United Kingdom, Russian Federation, France, Spain, Italy and Rest Of Europe By Country
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)